rs56163554

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_001003787.4(STRADA):​c.135G>A​(p.Ala45Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0022 in 1,613,312 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 12 hom. )

Consequence

STRADA
NM_001003787.4 synonymous

Scores

3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.242

Publications

1 publications found
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 17-63714097-C-T is Benign according to our data. Variant chr17-63714097-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212324.
BP7
Synonymous conserved (PhyloP=0.242 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00175 (266/151996) while in subpopulation SAS AF = 0.00705 (34/4824). AF 95% confidence interval is 0.00518. There are 1 homozygotes in GnomAd4. There are 134 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001003787.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
NM_001003787.4
MANE Select
c.135G>Ap.Ala45Ala
synonymous
Exon 5 of 13NP_001003787.1Q7RTN6-1
STRADA
NM_001363786.1
c.111G>Ap.Ala37Ala
synonymous
Exon 5 of 13NP_001350715.1
STRADA
NM_001363787.1
c.48G>Ap.Ala16Ala
synonymous
Exon 3 of 11NP_001350716.1A0A1W2PPJ9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
ENST00000336174.12
TSL:1 MANE Select
c.135G>Ap.Ala45Ala
synonymous
Exon 5 of 13ENSP00000336655.6Q7RTN6-1
STRADA
ENST00000392950.9
TSL:1
c.24G>Ap.Ala8Ala
synonymous
Exon 3 of 9ENSP00000376677.4Q7RTN6-2
STRADA
ENST00000375840.9
TSL:1
c.-40G>A
5_prime_UTR
Exon 4 of 12ENSP00000365000.4Q7RTN6-5

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
266
AN:
151878
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000387
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000788
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.000666
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00263
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00257
AC:
646
AN:
251348
AF XY:
0.00285
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00208
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00282
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00225
AC:
3288
AN:
1461316
Hom.:
12
Cov.:
31
AF XY:
0.00238
AC XY:
1732
AN XY:
726992
show subpopulations
African (AFR)
AF:
0.000897
AC:
30
AN:
33460
American (AMR)
AF:
0.00217
AC:
97
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39674
South Asian (SAS)
AF:
0.00619
AC:
534
AN:
86222
European-Finnish (FIN)
AF:
0.000281
AC:
15
AN:
53358
Middle Eastern (MID)
AF:
0.00850
AC:
49
AN:
5768
European-Non Finnish (NFE)
AF:
0.00212
AC:
2360
AN:
1111640
Other (OTH)
AF:
0.00290
AC:
175
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
155
311
466
622
777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00175
AC:
266
AN:
151996
Hom.:
1
Cov.:
32
AF XY:
0.00180
AC XY:
134
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.000386
AC:
16
AN:
41438
American (AMR)
AF:
0.000787
AC:
12
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00705
AC:
34
AN:
4824
European-Finnish (FIN)
AF:
0.000666
AC:
7
AN:
10514
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00263
AC:
179
AN:
68002
Other (OTH)
AF:
0.00427
AC:
9
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00231
Hom.:
0
Bravo
AF:
0.00162
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.00311
EpiControl
AF:
0.00356

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
1
-
not specified (1)
-
-
1
Polyhydramnios, megalencephaly, and symptomatic epilepsy (1)
-
-
1
STRADA-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_noAF
Benign
-0.24
CADD
Benign
9.4
DANN
Benign
0.88
PhyloP100
0.24
PromoterAI
0.084
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=293/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56163554; hg19: chr17-61791457; COSMIC: COSV55562080; COSMIC: COSV55562080; API